Description
Technical Overview
CJC-1295 (No DAC) + Ipamorelin is a research peptide blend formulated for laboratory investigation involving growth hormone secretagogue pathways and peptide interaction studies. This combination is commonly examined in controlled research settings for its role in supporting analysis of pulsatile growth hormone signaling and receptor-specific activity.
CJC-1295 (No DAC) is a modified growth hormone releasing hormone (GHRH) analog designed for research related to pituitary stimulation mechanisms, while Ipamorelin is a selective pentapeptide studied for its interaction with growth hormone secretagogue receptors (GHS-R). When combined, these compounds are frequently utilized in peptide research protocols exploring synergistic signaling behavior under controlled experimental conditions.
The blend is typically synthesized using established peptide manufacturing methods and purified through HPLC to achieve high analytical purity suitable for research and assay applications.
Specifications
Compound Name: CJC-1295 (No DAC) + Ipamorelin
Available Strengths: 5/5 mg · 10/10 mg
Format: Research Peptide Blend
Appearance: Lyophilized Peptide Powder
Purity: ≥ 99% (HPLC Verified)
Storage: −20°C recommended
Notice
This compound is provided strictly as a reference reagent for scientific and laboratory investigation.
Reviews
There are no reviews yet.